APA (7th ed.) Citation

H, Y., R, Y., Y, K., C, P., D, Y., H, Y., . . . M, S. (2026). Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: Implications for their interaction and clinical outcome. Cancer immunology, immunotherapy : CII, 75(3), . https://doi.org/10.1007/s00262-026-04327-w

Chicago Style (17th ed.) Citation

H, Yamada, et al. "Integrative Analysis of T Cell Subset-specific ICOS Expression and Tumor HLA Class I/II Expression in Lung Adenocarcinoma: Implications for Their Interaction and Clinical Outcome." Cancer Immunology, Immunotherapy : CII 75, no. 3 (2026). https://doi.org/10.1007/s00262-026-04327-w.

MLA (9th ed.) Citation

H, Yamada, et al. "Integrative Analysis of T Cell Subset-specific ICOS Expression and Tumor HLA Class I/II Expression in Lung Adenocarcinoma: Implications for Their Interaction and Clinical Outcome." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 3, 2026, https://doi.org/10.1007/s00262-026-04327-w.